Michael D. Clayman
2017
In 2017, Michael D. Clayman earned a total compensation of $1.1M as President, CEO and Co-Founder at Flexion Therapeutics, a 85% decrease compared to previous year.
Compensation breakdown
| Bonus | $495,000 |
|---|---|
| Salary | $548,108 |
| Other | $29,428 |
| Total | $1,072,536 |
Clayman received $548.1K in salary, accounting for 51% of the total pay in 2017.
Clayman also received $495K in bonus and $29.4K in other compensation.
Rankings
In 2017, Michael D. Clayman's compensation ranked 8,654th out of 14,666 executives tracked by ExecPay. In other words, Clayman earned more than 41.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,654 out of 14,666 | 41st |
Division Manufacturing | 3,290 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,109 out of 2,075 | 47th |
Industry group Drugs | 881 out of 1,731 | 49th |
Industry Pharmaceutical Preparations | 688 out of 1,333 | 48th |
Source: SEC filing on April 26, 2018.
Clayman's colleagues
We found three more compensation records of executives who worked with Michael D. Clayman at Flexion Therapeutics in 2017.